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The tail-anchored membrane protein, sarcolemmal membrane associated protein (SLMAP) is encoded to a single gene that maps
to the chromosome 3p14 region and has also been reported in certain diabetic populations. Our previous studies with db/db
mice shown that a deregulation of SLMAP expression plays an important role in type 2 diabetes. Male Tally Ho mice were bred
to present with either normoglycemia (NG) or hyperglycemia (HG). Abdominal adipose tissue from male Tally Ho mice of the
HG group was found to have a signiﬁcantly lower expression of the membrane associated glucose transporter-4 (GLUT-4) and
higher expression of SLMAP compared to tissue from NG mice. There were 3 isoforms expressed in the abdominal adipose tissue,
but only 45kDa isoform of SLMAP was associated with the GLUT-4 revealed by immunoprecipitation data. Knock down studies
using SLMAP siRNA with adipocytes resulted in a signiﬁcant reduction in SLMAP and a decrease in glucose uptake. Thus, SLMAP
may be an important regulator of glucose uptake or involved in GLUT-4 fusion/translocation into the plasma membrane of mouse
abdominal adipose tissue and changes in SLMAP expression are linked to hyperglycemia and diabetes.
1.Introduction
The etiology of type 2 diabetes is complex and involves
both genetic predisposition as well as environmental factors,
notably lifestyle and dietary inﬂuences, and has been closely
linked to the obesity epidemic [1, 2]. In the study of type
2 diabetes murine models have become an important tool
for determining the molecular basis for disease progression
and tissue dysfunction. In the db/db mouse type 2 diabetes
is linked to a dysfunctional leptin receptor, and the mouse
is hyperphagic, massively obese with marked hyperglycemia
and has been widely used for the study of type 2 diabetes [3,
4]. The Tally Ho mouse is a polygenic mouse model of type 2
diabetes that is susceptible to obesity [5]. It has been argued
that the Tally Ho mouse is a good model for human diabetes
asgeneticanalysisofthismousebyJacksonLaboratoriessug-
gested that diabetes is linked to a major susceptibility locus
on chromosome (Chr) 19 and interactions with additional
sites on Chr 16 [1] and with an obesity gene ob chromo-
some 6 [6].
Syntaxins are docking molecules that share the structure
of a very short COOH terminus and a long cytoplasmic
NH2-terminal region encompassing two coiled-coil domains
[7]. The SLMAPs, like several tail anchoring proteins, such
as syntaxin and soluble N-ethylmaleimide-sensitive factor
attachment protein receptor (SNARE), are involved in the
docking and membrane fusion process via protein-protein
interactions [8, 9]. Studies have shown that syntaxin and
SNARE-complex proteins are required in translocation of
glucose transporters GLUT-1 and GLUT-4 [10, 11].
Wehavereportedpreviouslythatendothelialdysfunction
in db/db mice is associated with a signiﬁcant upregulation
of the expression of the tail-anchored membrane protein,
SLMAP [12]. Furthermore, treatment with the PPARγ ago-
nist, COOH, reversed the endothelial dysfunction in db/db
mice and corrected the aberrant expression of vascular
SLMAP [12]. These data suggested that changes in the ex-
pression of the SLMAP gene might contribute to the de-
velopment of diabetes. The Tally Ho, like the db/db mouse,
also shows vascular and endothelial dysfunction [13, 14]. In2 Experimental Diabetes Research
the current study we have further pursued the link between
SLMAP expression and type 2 diabetes by utilizing the
polygenic type 2 diabetic Tally Ho mouse model. Tally Ho
mice also have a higher adiposity index compared to control
C57BL/6J mice [5], and our goal in the present study was
therefore to study SLMAP expression in Tally Ho mice
and determine whether there was a link with alterations in
adipocyte function, namely, GLUT-4 and glucose regulation.
2.MaterialsandMethods
2.1. Animals and Tissue Handling. Breeding pairs of Tally Ho
mice were purchased from Jackson Laboratories (Bar Har-
bor, ME, USA) and bred at Monash University, VIC,
Australia. In accordance with a protocol approved by RMIT
University Animal Ethics Committee, 24-week-old male
mice were sacriﬁced by cervical dislocation. It was originally
reportedthattheTally Ho miceexhibitmildobesity,hyperin-
sulinemia, hyperlipidemia, and male-speciﬁc hyperglycemia
and the animal colony was established through a selective
breeding process based on the hyperglycemic phenotypes
by choosing mating males showing high plasma glucose
levels and then inbreeding from hyperglycemic males and
apparentlynormalfemales[5].I nthisstud y ,w eha v eselect ed
the mice for the study groups according to plasma glucose
levels. The mice were separated into two groups according
to glucose levels with those below 12mmol/L placed in the
normoglycemic group (NG) and above 24mmol/L into the
diabetic hyperglycemic group (HG). The abdominal fat was
dissected out for Western blot and real-time PCR studies.
2.2. Real-Time PCR. Total RNA was extracted from abdom-
inal fat using an RNeasy Mini Kit with on-column DNase
treatment (QIAGEN), and ﬁrst-strand cDNA was sub-
sequently synthesized using a Superscript RT Kit (QIA-
GEN). Real-time PCR primers were designed as previously
described [12] with the addition that the expression levels
of GLUT-4 were also determined. The following primer
sequences for GLUT-4 were used: F: 5  CCTCCTGCTTG-
GCTTCTTC 3 ;R :5   GTTTCACCTCCTGCTCTAAAAG 3 .
As previously described [12] the sequence homology of the
isoforms for SLMAP prevents the primer designed for real-
time PCR from distinguishing between the diﬀerent SLMAP
isoforms, and thus the RT-PCR data reﬂects changes in
cumulativeSLMAPmessagelevelsforthetissuesandanimals
studied.
2.3. Antibodies, Immunoblotting, and Immunoprecipitation.
Adipose tissue was isolated from Tally Ho mice and homog-
enized in RIPA lysis buﬀer. Polyclonal antibodies against
SLMAP were characterized previously [15], and antibodies
against GLUT-4 and actin were purchased from Abcam
and Santa Cruz Biotechnology Inc. Protein samples (50ug
per lane) were separated by SDS-PAGE in the presence of
dithiothreitol and transferred to nitrocellulose membranes.
T h em e m b r a n e sw e r eb l o c k e dw i t h5 %m i l ki nT r i s - b u ﬀered
saline and incubated with primary antibody for 1h. The
nitrocellulose membranes were washed three times with
Tris-buﬀered saline-Tween (0.05%) solution and incubated
with horseradish peroxidase-conjugated second antibody for
1h. The reaction was visualized by chemiluminescence. The
Western blot data was quantiﬁed using Chemidoc densitom-
etry (Biorad).
2.4. Coimmunoprecipitation. Aliquots of lysate (300μgp r o -
tein) were incubated with 1μgo fn o r m a lr a b b i tI g G ,a n d
the lysates were precleared by the addition of 20μLo fp r o -
tein A/G-Sepharose (Santa Cruz Biosciences) for 1h. After
centrifugation, the resulting supernatant was incubated with
1μgofanti-SLMAPantibodyoranti-GLUT-4antibodyover-
night at 4◦C with gentle rocking. Immune complexes were
absorbed on protein G-Sepharose and washed 4 times with
PBS. Finally immunoblotting was performed as described
above.
2.5. Subcellular Fractionation. Subcellular protein fractions
from cytosolic and membrane components were extracted
using Qproteome cell compartment Kit (QIAGEN). Equal
protein content (20ug per lane) of fractions was analyzed by
SDS-PAGE and immunoblotting.
2.6. Adipocyte Cell Isolation and Culture. Adipose tissue (5-
6g)fromTally Ho mice was ﬁnely minced and gently shaked
for 60min at 37◦C in 50mL Krebs-Ringer bicarbonate
(KRB) buﬀer (in mmol/L: NaCl 118, MgSO4 1.2, CaCl2
1.3, NaHCO3 2.5, pH adjusted to 7.4 at 37◦C) containing
1mmol/L pyruvate, 1% bovine serum albumin, and 0.1%
collagenase. The cell suspension was then ﬁltered through a
nylon mesh (400μmol/L) and centrifuged at 100g for 1min
at room temperature. The supernatant was harvested and
washed three times with 50mL of KRB buﬀer containing
1mmol/L pyruvate and 1% BSA. Adipocytes were cultured
in Dulbecco’s modiﬁed Eagle’s medium (DMEM), 10% fetal
bovine serum, 100U/mL penicillin, and 100μg/mL strep-
tomycin. Culture media contained either 10mM or 30mM
glucose. 10mM and 30mM glucose were chosen for this
protocol as plasma glucose levels were comparable to those
reportedforthedb/dbleptinreceptormutantdiabeticmouse
as well as the Tally Ho mice in this study [16]. Cell cultures
were maintained in an incubator at 37◦C, with saturating
humidity and an atmosphere of 5% carbon dioxide to 95%
air.
2.7. 2-Deoxy[3H]Glucose Uptake Measurement. Cells were
seeded into 6-well plates. After reaching 80% conﬂuence,
the cells were washed and incubated with 800 uL of DMEM
(0.1% FBS) containing 1uCi of 2-Deoxy-D-Glucose (Perkin
Elmer) and 10uM of nonradiolabeled glucose (Sigma) for
30min. The cells were treated with SLMAP or negative
control siRNAs. After incubation the cells were washed with
1mL ice-cold PBS 3x then lysed with 1mL NaOH (0.3M).
800uL of the lysate was then used for glucose uptake assay,
and the remaining lysates were used for protein assay.
2.8. SLMAP Knockdowns. SLMAP and negative control
siRNAs were purchased from QIAGEN based on sequencesExperimental Diabetes Research 3
of mouse SLMAP (Accession no. NM 032008). The single-
stranded siRNA sequences targeting SLMAP were 5 -CGU-
GAUGUGCAUGAUUUAAd(-TT)-3  and 5 -AGAUGA-
AGAUAGACUCUUAd(TT)-3 ,a n ds e q u e n c ef o rn e g a -
tivecontrolwasACGUGACACGUUCGGAGAAd(TT).After
reaching 80% conﬂuence cultured in DMEM with 10% FCS
and antibiotics as described earlier, cells were transfected
with 5nM siRNA using HiPerfect Transfection Reagent in
a 6-well plate according to the manufacturer’s instructions.
After 72h of incubation, SLMAP expression and glucose
uptake were studied.
2.9. Data Analysis. In all experiments n equals the number
of animals used in the protocol. Statistical signiﬁcance of
diﬀerence between means of diﬀerent groups was performed
using Student’s t-test or one-way ANOVA. A value of P<
0.05 was considered statistically signiﬁcant.
3. Results
Tally Ho mice were assigned into two groups according to
their blood glucose level. The normoglycemic group (NG)
mice had blood glucose level lower than 12mmol/L, while
the hyperglycemic group (HG) mice had blood glucose
higherthan24mmol/L.ThemeanbloodglucoselevelsinNG
and HG groups were 9.9 ± 1.1a n d2 7 .3 ± 3.4, respectively
(P<0.05). The body weights and serum insulin level were
comparable between the NG nondiabetic Tally Ho mice and
the HGdiabetic Tally Ho mice (35.0±2.8gversus33.3±1.2g
and 0.9 ± 0.3ug/L versus 0.6 ±0.2ug/L) (P>0.05).
GLUT-4 protein expression in adipose tissue from
HG mice was signiﬁcantly higher than that in NG mice
(Figure 1(a)). There was a 3.3 ± 0.5-fold increase of GLUT-
4 expression in adipose tissue from HG Tally Ho mice
compared to that from NG mice (Figure 1(b)) (P<0.05).
Real-time PCR showed that the GLUT-4 mRNA transcript
levelsofadiposetissuefromHGTally Ho micewere6.4±1.2-
fold higher compared with those from NG Tally Ho mice
(Figure 1(c)) (P<0.05). However, compartmentalization
studies showed that increased total GLUT-4 expression from
adipose tissue of HG mice contributed to signiﬁcantly
increased GLUT-4 expression in the cytosolic fraction while
membrane-bound GLUT-4 was signiﬁcantly decreased com-
pared to that from adipose tissue of NG mice (Figures 1(d)
and 1(e)) (P<0.05).
Speciﬁc antibodies raised against SLMAP fusion protein
were used to study SLMAP expression in the Tally Ho mouse
adipose tissue. Figure 2(a) shows that the anti-SLMAP anti-
body recognized three polypeptides of approximately 90, 45,
and 35kDa in adipose tissue from both NG and HG Tally Ho
mice. The SLMAP expression proﬁle in the adipose tissue
revealed that the levels of expression of the 45kDa and the
35kDa SLMAP protein in adipose tissue from HG mice were
markedlyhigherthanthosefromNGmice(Figure 2(a)).The
90KDa isoform was not signiﬁcantly diﬀerent between NG
and HG Tally Ho mice. The Western blot data of the SLMAP
expression were quantiﬁed, and it was evident that HG
Tally Ho mice exhibited a 1.9 ± 0.1-fold increase in ex-
pression of the 45kDa and a 2.0 ± 0.2-fold increase in
the 35kDa SLMAP isoforms compared to NG Tally Ho
mice (Figure 2(b))( P<0.05). Thus, these results indicate
that the expressions of the 45kDa and the 35kDa SLMAP
isoforms were specifically enhanced in adipose tissue from
HG Tally Ho mice.
SLMAP transcript levels of adipose tissue from NG and
HG Tally Ho mice were also examined by real-time PCR.
mRNA levels of SLMAP were 6.1 ± 0.9-fold higher in the
adipose tissue (Figure 2(c))( P<0.05) from HG Tally Ho
mice compared with that from NG Tally Ho mice.
Compartmentalization studies showed that the 90kDa
isoformofSLMAPwaspredominant inthecytosolicfraction
while the 35 and 45kDa isoforms were mainly in the mem-
brane fraction (Figure 2(d)). There were a 2.0 ± 0.2f o l d
increase and a 2.3±0.2 fold increase of membrane-bound 35
and 45kDa isoforms, respectively, in adipose tissue from HG
Tally Ho mice compared with that from NG Tally Ho mice
(Figure 2(e))( P<0.05).
Subcellular membrane and cytosolic fractions were im-
munoprecipitated with GLUT-4 antibody and immunoblot-
ted by SLMAP antibody. Even though both 45 and 35kDa
SLMAP isoforms were expressed in the membrane fraction,
only the 45kDa isoform was detected by Western blot. The
association of GLUT-4 and SLMAP was signiﬁcantly de-
creased to 68.5% ± 6.3 in HG mice compared to that in NG
mice (Figures 3(a) and 3(b)) (P<0.05). The association of
GLUT-4 and SLMAP was also studied by immunoprecipita-
tion with SLMAP antibody and immunoblotted by GLUT-
4 antibody in the subcellular membrane fractions. The
association of GLUT-4 and SLMAP was decreased to 38.6 ±
2.0% compared to that observed in NG mice (Figures 3(c)
and 3(d)) (P<0.05). However, no band could be detected
using cytosolic fraction and immunoprecipitation (data not
shown).
AdipocytesisolatedfromNGTally Ho micewerecultured
in 10mM (NG) or 30mM (HG) glucose culture media for
3 days. The SLMAP expression proﬁle revealed that the
90kDa SLMAP was the predominant isoform and was not
signiﬁcantly diﬀerent between the adipocytes in NG media
andHGmedia.Thelevelsofexpressionofthe45kDaandthe
35kDa SLMAP protein in adipocytes cultured in HG media
were markedly higher than those cultured in NG media (Fig-
ure4(a)). The Western blot data for SLMAP expression were
quantiﬁed, and there were a 1.6±0.1-fold increase in expres-
sion of the 45kDa and a 2.1±0.2-fold increase in the 35kDa
SLMAP isoforms in adipocytes cultured in HG compared
to expression levels in NG (Figure 4(b))( P<0.05). mRNA
levels of SLMAP were 1.5 ±0.2-fold higher in the adipocytes
cultured in HG compared to those in NG (Figure 4(c))
(P<0.05). There were no signiﬁcant diﬀerence for mRNA
and protein expression levels of GLUT4 between adipocytes
cultured in HG and NG media (Figures 4(a), 4(d),a n d4(e))
(P>0.05). There was no signiﬁcant diﬀerence between
glucose uptake in adipocytes treated with NG compared to
uptake in those treated with HG (Figure 4(f))( P>0.05).
After adipocytes were treated with SLMAP siRNA for
3 days, total SLMAP protein expression for all isoforms
was signiﬁcantly decreased to 38.7% ± 4.6 when compared4 Experimental Diabetes Research
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Figure 1: Expression of GLUT-4 in adipose tissue in Tally Ho mice. Adipose tissue from both NG and HG Tally Ho mice was isolated and
analyzed by immunoblotting with anti-GLUT-4 (a). The expression of the GLUT-4 was quantiﬁed by densitometry and is shown as bar
graph (b). Real-time PCR for GLUT-4 message normalized to β-actin from both NG and HG Tally Ho mice (c). Subcellular membrane
fractions Cyto (cytosolic fraction) and Mem (membrane fraction) from adipose tissue in both NG and HG Tally Ho mice were analyzed by
immunoblotting with anti-GLUT-4 (d). The expression of GLUT-4 from cytosolic and membrane fractions was quantiﬁed by densitometry
and is shown as bar graph (e). The data are expressed as mean ± SEM. 4 to 6 mice were included in each group. ∗Signiﬁcantly diﬀerent
(P<0.05) n = 4.
to SLMAP protein levels in adipocytes treated with neg-
a t i v ec o n t r o ls i R N A( F i g u r e s5(a) and 5(b))( P<0.05).
There was no signiﬁcant diﬀerence in GLUT4 expression
in adipocytes following treatment with SLMAP or nega-
tive control siRNAs (data not shown). Glucose uptake in
adipocytes treated with SLMAP siRNA was signiﬁcantly
decreased to 61.7% ± 7.1c o m p a r e dt ou p t a k ei na d i -
pocytes treated with negative control siRNA (Figure 5(c))
(P<0.05).
4. Discussion
The new ﬁndings from the present study are the following.
Firstly, in abdominal adipocytes from the Tally Ho mouse,
a polygenic model of type 2 diabetes, there was an upreg-
ulation of the 45 and 35KDa isoforms of the tail-anchored
membrane protein SLMAP in HG mice. The expression of
these two isoforms in adipocytes isolated from NG mice
is also upregulated after culturing in HG medium. BothExperimental Diabetes Research 5
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Figure 2: Expression of SLMAP isoforms in adipose tissue in Tally Ho mice. Adipose tissue was isolated and analyzed by immunoblotting
with anti-SLMAP (a). Anti-SLMAP immunoreactive proteins are depicted by arrows, and the positions of migration of the molecular weight
standards are shown as numbers in (kilodaltons). The expressions of the 90, 45, and 35kDa SLMAP from adipose tissue in both NG and HG
Tally Ho mice were quantiﬁed by densitometry and are shown as bar graph (b). Real-time PCR for SLMAP message normalized to β-actin
from both NG and HG Tally Ho mice (c). Subcellular membrane fractions Cyto (cytosolic fraction) and Mem (membrane fraction) from
adipose tissue in both NG and HG Tally Ho mice were analyzed by immunoblotting with anti-SLMAP (d). The expression of the 35 and
45kDa isoforms of SLMAP from membrane fraction was quantiﬁed by densitometry and shown as bar graph (d,e). The data are expressed
as mean ± SEM. 4 to 6 mice were included in each group. ∗Signiﬁcantly diﬀerent (P<0.05) n = 4.6 Experimental Diabetes Research
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Figure 3:ImmunoprecipitationforSLMAPandGLUT-4insubcellularmembranefractionsfromadipcytes.Subcellularmembranefractions
were immunoprecipitated with GLUT-4 and SLMAP antibody and immunoblotted by SLMAP and GLUT-4 antibody, respectively (a,c). The
protein expression levels were quantiﬁed by densitometry and are shown as bar graph (b,d). ∗Signiﬁcantly diﬀerent (P<0.05) n = 4.
isoforms were predominantly expressed in the membrane
fraction. Secondly, although both the mRNA and protein
expression levels of GLUT-4 were signiﬁcantly elevated in
adipose tissue from HG Tally Ho mice, membrane-bound
GLUT-4 was decreased compared to NG Tally Ho mice.
Thirdly, immunoprecipitation data indicated that there was
anassociationofGLUT-4withthe45kDamembrane-bound
isoformofSLMAPthussuggestingapossibleroleforSLMAP
in the regulation of glucose transport. In addition, even
though both the association of GLUT-4 with SLMAP and
membrane-bound GLUT-4 were decreased in abdominal
adipocytes from HG compared to those from NG, there was
no diﬀerence between glucose uptake in adipocytes treated
with NG and HG suggesting a possible compensatory role
of up regulated SLMAP. Fifth and ﬁnally, when expression
of SLMAP was knocked down in adipocytes with siRNA,
glucose uptake was signiﬁcantly decreased. Collectively these
datasuggestthatSLMAPisinvolvedinGLUT-4regulationin
adipose tissue and abnormalities in the regulation of SLMAP
expression in adipose tissue from diabetic Tally Ho mice may
be linked to alterations in glucose transport and the etiology
of diabetes in this animal.
The data presented in the current study is in accordance
with data from the leptin-receptor-deﬁcient (db/db)m i c e
whichalsoexhibitsthetypicalfeaturesoftype2diabeteswith
hyperglycemia, dyslipidemia, and hyperinsulinemia [17–
22]. We have previously reported that the vasculature was
dysfunctional in db/db mice and this functional impairment
was closely associated with a marked dysregulation in
expression of the tail-anchored membrane protein SLMAP
in the db/db microvasculature [12]. The reduced endothelial
function in the db/db vasculature was accompanied by a 2.7-
fold increase in the expression of a 35kDa SLMAP isoform.
It is noteworthy that SLMAP upregulation was unaltered in
the myocardium from these animals suggesting that changes
in SLMAP regulation are not simply a secondary response to
the diabetic state, that is, hyperglycemia.
Of interest is that the vasculature of the Tally Ho mouse
shows similar endothelial and vascular dysfunction as that
reportedforthedb/dbmouse[13,14,23].Anupregulationof
the 45 and 35KDa isoforms of the tail-anchored membrane
proteinSLMAPisevidentinbothadipocytesandvasculature
but not in skeletal muscle and heart in HG Tally Ho mice
(Ding, unpublished data). The present data linking dysregu-
lation of SLMAP expression to GLUT-4 in adipocytes from
Tally Ho mice reinforces our conclusion that a dysregulation
of SLMAP expression is linked, in a tissue-speciﬁc manner,
to diabetes.
SLMAPs deﬁne a new family of tail-anchored mem-
brane proteins that exhibit tissue-speciﬁc expression withExperimental Diabetes Research 7
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Figure 4:SLMAPexpressioninadipocytes.RepresentativegelsforproteinexpressionofSLMAP,GLUT-4,andβ-actininadipocytescultured
with 10mM (NG) and 30mM glucose (HG) for 3 days by Western blot method (a); data quantiﬁed by densitometry and are shown as bar
graph for SLMAP (b) and GLUT-4 (d). Real-time PCR for SLMAP (c) and GLUT-4 (e) message normalized to β-actin from both adipocytes
culturedwithNGandHGfor3days.GlucoseuptakewasmeasuredinbothadipocytestreatedwithNGandHGusingradiolabeled2-Deoxy-
D-Glucose and data expressed in the bar graphs (f). ∗Signiﬁcantly diﬀerent (P<0.05) n = 4.8 Experimental Diabetes Research
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Figure 5: knockdown SLMAP using siRNA in adipocytes. Representative gel for adipocytes treated with SLMAP siRNA to knockdown
SLMAP and those treated with a scrambled siRNA as negative control (a). The total expression of SLMAP was quantiﬁed by densitometry
and shown as bar graph (b). Glucose uptake was measured in both adipocytes treated with SLMAP siRNA and negative control using
radiolabeled 2-Deoxy-D-Glucose and data expressed in the bar graphs (c). ∗Signiﬁcantly diﬀerent (P<0.05) n = 4.
the highest level of expression seen in cardiac and smooth
muscle [15, 24]. SNAREs are tail-anchored membrane
proteins known to regulate GLUT-4 translocation in diabetic
models [25]. SNAREs play an important role in regulating
insulin-stimulated translocation of GLUT-4 from an in-
tracellular compartment to plasma membrane and glucose
uptake in adipose tissue. Our preliminary data demonstrated
that SLMAP protein levels can be modulated by insulin-
resistant states and by agents that increase insulin sensitivity
[12]. Maier et al. reported that GLUT-4 levels in skeletal
muscle from Zucker diabetic rats were similar to those in
lean control rats; however, SNAREs were elevated in skeletal
muscle from Zucker diabetic rats [26]. Restoration of nor-
moglycemia and normoinsulinemia in Zucker rats with
rosiglitazone normalized SNARE protein levels; however, an
elevation of SNAREs was not seen in the streptozotocin-
induced diabetic rat leading to the conclusion that changes
in SNARE expression are linked to hyperinsulinemia rather
thanhyperglycemia.Indb/dbmicetreatmentwiththePPARγ
agonist COOH also normalized metabolic dysfunction and
SLMAP expression in the microvasculature [12]. In this
study, we have selected the mice for the study groups ac-
cording to plasma glucose levels. Although, in the mice we
studied, there is no signiﬁcant diﬀerence in the insulin levels
between NG and HG groups, this is consistent with other
studies that show only mild hyperinsulinemia or reduced
insulin secretion of Tally Ho mice. For instance, Sung et al.
have measured plasma insulin concentrations during oral
glucose tolerance test and found that the plasma insulin con-
centrations were lower in Tally Ho mice than in C57BL/6
mice [27]. The Tally Ho mice investigated in the current
study although hyperglycemic did not have elevated insulin
levels thus suggesting that expression of SLMAP is aﬀected
by hyperglycemia and not insulin.Experimental Diabetes Research 9
Cells cotransfected with constructs encoding Myc-
SLMAP and GFP-SLMAP variants conﬁrmed that SLMAPs
were homodimerized [28]. The ability of SLMAPs to reside
in diﬀerent membrane systems and to homodimerize may
allowthismoleculetoservearoleinmembraneorganization.
Changes in vesicle transport, which is critical for the move-
ment and recycling of proteins such as GLUT-4, to and from
the cell surface may lead to changes in glucose handling.
NumerousSNARE-relatedproteinshaveparticularcellu-
lar and organellar speciﬁcity, and each protein demonstrates
apparent speciﬁcity for a single kind of vesicle or target
membrane to ensure vesicle-to-target speciﬁcity [29]. Tail-
anchored proteins show selectivity to their targets by post-
translational modiﬁcation such as N-glycosylation. Insertion
of a C-terminal N-glycosylation sequence into the tail-
anchored protein cytochrome b5 resulted in localization
exclusively to mitochondrial outer membrane instead of en-
doplasmic reticulum [30]. The alternative exons XI, XII, and
XIII of the SLMAP gene were predicted to introduce post-
translational modiﬁcations sites including phosphorylation
forPKC,aswellasN-glycosylationandN-myristoylation[9].
Further studies are required to test if alterations of SLMAP
phosphorylation and glycosylation in hyperglycemia may
cause malfunction and mislocalization of SLMAP that leads
to alteration of GLUT-4 and regulation of glucose transpor-
tation.
In adipocytes from HG Tally Ho mice, the expression of
SLMAP was signiﬁcantly increased; however, the association
between SLMAP and GLUT-4 was decreased in hyperglyce-
mic conditions. Glucose uptake in adipocytes treated with
NG or HG remained unchanged. We thus hypothesized that
SLMAP expression was up regulated to compensate for a
decreased role of SLMAP in GLUT-4 transfer/fusion to the
plasma membrane. That glucose uptake of adipocytes iso-
lated from Tally Ho mice was signiﬁcantly decreased after
siRNA knockdown of SLMAP expression supports a role for
SLMAP in the regulation of glucose transporters.
In conclusion, in adipose tissue both the tail-anchored
membrane protein SLMAP and GLUT-4 expression are up
regulated in HG Tally Ho mice. However, the association
between GLUT-4 and SLMAP was decreased in the diabetic
mice when compared to the NG controls, perhaps reﬂecting
that changes in SLMAP expression play a compensatory role
in diabetes. The association between GLUT-4 and SLMAP in
adipocytesandtheabilityofsiRNAknockdownofSLMAPto
reduce both SLMAP expression and glucose uptake suggests
a possible regulatory role of SLMAP in GLUT-4 fusion and
translocation to the plasma membrane and in the regulation
of glucose uptake. The altered association of GLUT-4 and
SLMAPinthehyperglycemicstatesuggeststhatalterationsin
theregulationofSLMAPexpressionmightplayanimportant
role in the development of diabetes.
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